Sign in
8-K

Current Report

Altimmune, Inc. Filed Acc 0001144204-17-025266

Acquisition or sale completed · Delisting notice · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 3.03 Material modification to rights of security holders
  • Item 4.01 Changes in the registrant's certifying accountant
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading v466109_8k.htm…